Ceptyr is a developer of protein tyrosine phosphatase (PTP) -based therapeutics.
Ceptyr, Inc was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored niche in pharmaceutical development.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 23, 2002 | Series Unknown | $20M | 1 | — | — | Detail |
Aug 18, 1999 | Series Unknown | $11.50M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | — | Series Unknown |
Falcon | — | Series Unknown |